Everolimus Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg
Reference Brands: Zortress, Afinitor(US & EU)
Category: Immune Disorder
Everolimus inhibits mTOR, blocking cell growth, proliferation, and survival. It effectively treats cancers, such as neuroendocrine tumors, breast cancer, and renal cell carcinoma, and prevents organ rejection in transplants. Benefits include targeted therapy, improved progression-free survival, and manageable side effects, supporting long-term disease management.
Product Description: Everolimus tablets, marketed as Afinitor and Zortress, are approved in the US by the FDA and in the EU via EMA for various indications including cancer and transplant rejection. Regulatory approval requires a comprehensive dossier containing clinical trial data, manufacturing details, safety, efficacy, and pharmacovigilance strategies. In the US, FDA review involves stringent evaluation of clinical and quality data, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market accession, visit PharmaTradz. Ensuring thorough regulatory compliance is critical for the safe, effective, and timely approval of everolimus tablets worldwide, supporting optimal patient outcomes in oncology and transplantation.
Everolimus Tablets — third party manufacturing & bulk supply
Everolimus Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Everolimus Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Everolimus Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Everolimus Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Etrasimod Arginine
Strength:
2 mg, 4 mg, 6 mg
Form: Tablets
Reference Brands: Velsipity (USA)
View Details
Fostamatinib Disodium
Strength:
100 mg, 150 mg
Form: Tablets
Reference Brands: Tavalisse (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
